Child with Hemophilia A presenting claw hand deformity treated with Emicizumabe: excellent clinical result associated to lower financial cost

• Tác giả chính: Sylvia Thomas (Tác giả)
• Định dạng: Sách
• Được phát hành: Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia, 2022-12-01T00:00:00Z.
• Những chủ đề: article
• Truy cập trực tuyến: Connect to this object online.

Objective: Exemplify how prophylaxis using Emicizumabe (EMZ) in children with Hemophilia A can be more effective and less costly than standard management. Patients presenting antibodies against Factor VIII are treated with prophylactic intravenous bypassing medicines, e.g., recombinant Factor VIIa (...